Literature DB >> 21732238

Control of ADAR1 editing of hepatitis delta virus RNAs.

John L Casey1.   

Abstract

Hepatitis delta virus (HDV) uses ADAR1 editing of the viral antigenome RNA to switch from viral RNA replication to packaging. At early times in the replication cycle, the virus produces the protein HDAg-S, which is required for RNA synthesis; at later times, as result of editing at the amber/W site, the virus produces HDAg-L, which is required for packaging, but inhibits further RNA synthesis as levels increase. Control of editing during the replication cycle is essential for the virus and is multifaceted. Both the rate at which amber/W site editing occurs and the ultimate amount of editing are restricted; moreover, despite the nearly double stranded character of the viral RNA, efficient editing is restricted to the amber/W site. The mechanisms used by the virus for controlling editing operate at several levels, and range from molecular interactions to procedural. They include the placement of editing in the HDV replication cycle, RNA structural dynamics, and interactions of both ADAR1 and HDAg with specific structural features of the RNA. That HDV genotypes 1 and 3 use different RNA structural features for editing and control the process in ways related to these features underscores the critical roles of editing and its control in HDV replication. This review will cover the mechanisms of editing at the amber/W site and the means by which the virus controls it in these two genotypes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21732238      PMCID: PMC3572862          DOI: 10.1007/82_2011_146

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  50 in total

1.  Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture.

Authors:  Jinhong Chang; Severin O Gudima; John M Taylor
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing.

Authors:  Sarah D Linnstaedt; Wojciech K Kasprzak; Bruce A Shapiro; John L Casey
Journal:  RNA       Date:  2006-06-21       Impact factor: 4.942

3.  Transcription of hepatitis delta virus RNA by RNA polymerase II.

Authors:  Jinhong Chang; Xingcao Nie; Ho Eun Chang; Ziying Han; John Taylor
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

4.  Hepatitis delta antigen binds to the clamp of RNA polymerase II and affects transcriptional fidelity.

Authors:  Yuki Yamaguchi; Takashi Mura; Sittinan Chanarat; Sachiko Okamoto; Hiroshi Handa
Journal:  Genes Cells       Date:  2007-07       Impact factor: 1.891

Review 5.  Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades?

Authors:  P Dény
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

6.  Titration of the infectivity of hepatitis D virus in chimpanzees.

Authors:  A Ponzetto; B H Hoyer; H Popper; R Engle; R H Purcell; J L Gerin
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

7.  Hepatitis delta virus inhibits alpha interferon signaling.

Authors:  Paolo Pugnale; Valerio Pazienza; Kévin Guilloux; Francesco Negro
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

8.  RNA editing of the human herpesvirus 8 kaposin transcript eliminates its transforming activity and is induced during lytic replication.

Authors:  Sharon Z Gandy; Sarah D Linnstaedt; Sumitra Muralidhar; Kathleen A Cashman; Leonard J Rosenthal; John L Casey
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

9.  The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells.

Authors:  D Hartwig; C Schütte; J Warnecke; I Dorn; H Hennig; H Kirchner; P Schlenke
Journal:  J Viral Hepat       Date:  2006-03       Impact factor: 3.728

10.  Hepatitis delta antigen requires a minimum length of the hepatitis delta virus unbranched rod RNA structure for binding.

Authors:  Dawn A Defenbaugh; Matthew Johnson; Renxiang Chen; Ying Yi Zheng; John L Casey
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

View more
  32 in total

1.  Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.

Authors:  Guangyan Liu; Xiancai Ma; Zhe Wang; Kousho Wakae; Yaochang Yuan; Zhangping He; Hironori Yoshiyama; Hisashi Iizasa; Hui Zhang; Mami Matsuda; Ryuichi Sugiyama; Zhiyu Yuan; Masamichi Muramatsu; Linghua Li
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

Review 2.  Life cycle and pathogenesis of hepatitis D virus: A review.

Authors:  Zaigham Abbas; Rafia Afzal
Journal:  World J Hepatol       Date:  2013-12-27

Review 3.  ADARs: viruses and innate immunity.

Authors:  Charles E Samuel
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

4.  Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication.

Authors:  Marwa Khabir; Asma Zahra Aliche; Camille Sureau; Matthieu Blanchet; Patrick Labonté
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

Review 5.  Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response.

Authors:  Christian K Pfaller; Zhiqun Li; Cyril X George; Charles E Samuel
Journal:  Curr Opin Immunol       Date:  2011-09-15       Impact factor: 7.486

6.  Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR.

Authors:  Shili Zhou; Chao Yang; Fanfan Zhao; Yanxia Huang; Yuxia Lin; Changbai Huang; Xiaocao Ma; Jingjie Du; Yi Wang; Gang Long; Junfang He; Chao Liu; Ping Zhang
Journal:  J Biol Chem       Date:  2019-10-21       Impact factor: 5.157

Review 7.  An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).

Authors:  Cyril X George; Lijo John; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2014-06       Impact factor: 2.607

8.  Arginine-rich motifs are not required for hepatitis delta virus RNA binding activity of the hepatitis delta antigen.

Authors:  Leighton H Daigh; Brittany L Griffin; Ali Soroush; Murad R Mamedov; John L Casey
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

9.  Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.

Authors:  Wenhui He; Zhiliang Cao; Fengfeng Mao; Bijie Ren; Yunfei Li; Dan Li; Huiyu Li; Bo Peng; Huan Yan; Yonghe Qi; Yinyan Sun; Fengchao Wang; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.

Authors:  Shengyong Yang; Peng Deng; Zhaowei Zhu; Jianzhong Zhu; Guoliang Wang; Liyong Zhang; Alex F Chen; Tony Wang; Saumendra N Sarkar; Timothy R Billiar; Qingde Wang
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.